Skip to main content

Table 1 Different biochemical data in the studied groups

From: Vitamin D receptor gene polymorphism and hepatocellular carcinoma in chronic hepatitis C patients

 

Group A

Control

(n = 34)

Group B

HCC

(n = 34)

Group C

chronic hepatitis (n = 34)

P value

Age

49.3 ± 6.5

53.8 ± 8.3a

50.9 ± 6.9

0.06*

Gender (M/F)

16/18

23/11

17/17

0.182

BMI (kg/ m2)

23.09 ± 0.45

23.19 ± 0.47

23.16 ± 0.49

0.668

Total bilirubin (mg/dl)

0.85 ± 0.17

2.32 ± 1.33a

1.87 ± 1.14b

0.005*

Direct bilirubin (mg/dl)

0.39 ± 0.11

0.81 ± 0.58a

0.97 ± 0.67b

0.032*

ALT (IU/L)

25 ± 3.55

97.79 ± 25.32a

91.41 ± 60.27b

< 0.001**

AST (IU/L)

22.67 ± 4.28

77.71 ± 21.53a

93.94 ± 85.15b

< 0.001**

Albumin (g/dl)

4.22 ± 0.44

2.82 ± 0.71a

3.06 ± 0.47b

< 0.001**

ALP (IU/L)

64.35 ± 11.39

108.97 ± 37.7a

112.38 ± 57.31b

< 0.001**

AFP (ng/mL)

6.45 ± 1.63

3599.09 ± 4450.75a

26.13 ± 23.87c

< 0.001**

Creatinine (mg/dL)

0.87 ± 0.12

1.04 ± 0.27a

0.94 ± 0.19

0.004*

Urea (mg/dL).

33.85 ± 3.74

31.59 ± 3.89a

33.15 ± 2.87

0.029*

Hemoglobin (g/dL)

12.71 ± 0.76

12.28 ± 1.61a

12.03 ± 1.61b

0.125

Platelets count (× 103 mm3)

222 ± 49.14

134.97 ± 7.13a

130.77 ± 73.72b

< 0.001**

INR

1.02 ± 0.04

1.38 ± 0.39a

1.49 ± 0.43b

< 0.001**

PT (s)

12.27 ± 0.46

16.68 ± 4.91a

17.89 ± 5.17b

< 0.001**

  1. *P < 0.05 is significant
  2. **P < 0.001 is highly significant
  3. aSignificant difference between group A (control) and B(HCC)
  4. bSignificant difference between group A (control) and C(chronic hepatitis)
  5. cSignificant difference between group B (HCC) and C(chronic hepatitis)